Events

Murali Prahalad, Ph.D., president and CEO, will give a presentation entitled, “CTCs Come of Age as Biomarkers” at the Personalized Medicine World Conference (PMWC) 2015

Data presented on 1) PD-L1 assay on circulating tumor cells identified in a liquid biopsy from non-small cell lung cancer patients and 2) a new assay for NSCLC Biomarkers, including EGFR, KRAS, ALK, MET, RET and ROS1, utilizing both circulating tumor cells (CTC) and circulating free DNA (cfDNA) from a single tube of blood

Poster Display Session 28.09.2014 | 12:45 - 13:45 Characteristics of de novo resistance to androgen targeting therapeutics (AR Tx) through circulating tumor cells (CTCs) analysis in metastatic castration resistant prostate cancer (mCRPC) patients R. Bambury, J. Louw, R. Krupa, D. Danila, Z. Arslan, N. Schreiber, A. Jendrisak, D. Marrinucci, R. Dittamore, H. Scher

In collaboration with the company's academic and pharmaceutical partners, Epic's technology will be featured in two talks and two posters at the 105th Annual Meeting of the American Association for Cancer Research (AACR), April 5-9, 2014 in San Diego.

Studies address technical sensitivity, specificity, pharmacodynamics, heterogeneity, and patient selection relevant to prostate cancer patient management

SAN DIEGO and ORLANDO, FLA. - February 12, 2013 -- Epic Sciences, Inc. ("Epic"), a private biotech company that develops breakthrough cancer diagnostics, announced the presentation of a research poster at the 2013 Genitourinary Cancers Symposium taking place February 14 to 16 in Orlando, Fla. The symposium presents the latest research in genitourinary cancers and is sponsored by three leading medical specialty societies: American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO).

Epic Sciences will be at the following 2012 conferences and events:

Epic Sciences will be at the following 2012 conferences and events:

Epic Sciences will be attending the annual World CTC Summit at the Se Hotel in San Diego from November 8-10th, 2011 and presenting "A Novel Approach for Finding and Characterizing CTCs" on November 9th at 5:00pm.